JP Morgan Chase & Co. Assessment of Bayer Stock - Key Highlights

Wednesday, 17 July 2024, 11:52

JP Morgan Chase & Co. has maintained a "Neutral" rating on Bayer stock with a target price of 34 Euro. Analyst Richard Vosser provided insights on the latest study findings, offering a balanced perspective on Bayer's performance.
LivaRava Finance Meta Image
JP Morgan Chase & Co. Assessment of Bayer Stock - Key Highlights

Overview

JP Morgan Chase & Co. has reiterated a 'Neutral' rating for Bayer stock, setting a price target of 34 Euro.

Key Analysis

Analyst: Richard Vosser

  • Rating: Neutral
  • Target Price: 34 Euro

Conclusion

Impartial View: JP Morgan Chase & Co.'s assessment offers a comprehensive view of Bayer's stock performance, providing valuable insights for investors.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Get the most reliable and up-to-date financial news with our curated selections. Subscribe to our newsletter for convenient access and enhance your analytical work effortlessly.

Subscribe